Interface-formation processes in atomic layer deposition (ALD) of Al₂O₃ on InGaAs surfaces were investigated using on-line Auger electron spectroscopy. Al₂O₃ ALD was carried out by repeating a cycle of Al(CH₃)₃ (trimethylaluminum, TMA) adsorption and oxidation by H₂O. The first two ALD cycles increased the Al KLL signal, whereas they did not increase the O KLL signal. Al₂O₃ bulk-film growth started from the third cycle. These observations indicated that the Al₂O₃/InGaAs interface was formed by reduction of the surface oxides with TMA. In order to investigate the effect of surface-oxide reduction on metal-insulator-semiconductor (MIS) properties, capacitors and field-effect transistors (FETs) were fabricated by changing the TMA dosage during the interface formation stage. The frequency dispersion of the capacitance-voltage characteristics was reduced by employing a high TMA dosage. The high TMA dosage, however, induced fixed negative charges at the MIS interface and degraded channel mobility.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5448916 | PMC |
http://dx.doi.org/10.3390/ma5030404 | DOI Listing |
Polymers (Basel)
December 2024
School of Civil Engineering and Architecture, Nanchang University, 999 Xuefu Avenue, Nanchang 330031, China.
Anion exchange membranes (AEMs) as a kind of important functional material are widely used in fuel cells. However, synthetic AEMs generally suffer from low conductivity, poor alkaline stability, and poor dimensional stability. Constructing efficient ion transport channels is widely regarded as one of the most effective strategies for developing AEMs with high conductivity and low swelling ratio.
View Article and Find Full Text PDFTaiwan J Obstet Gynecol
November 2024
Department of Obstetrics and Gynecology, National Taiwan University Hospital, Taipei City, Taiwan; Department of Obstetrics and Gynecology, College of Medicine, National Taiwan University, Taipei City, Taiwan. Electronic address:
J Diabetes Complications
December 2024
Hospital Universitario Fundación Jiménez Díaz, Avda. Reyes Católicos, 2, CP 28040 Madrid, Madrid, Spain; Hospital Universitario Infanta Elena, Avda. Reyes Católicos 21, CP 28340 Valdemoro, Madrid, Spain; Hospital Universitario General de Villalba, Carretera de Alpedrete a Moralzarzal M-608 Km 41. CP2 8400 Collado Villalba, Madrid, Spain; Hospital Universitario Rey Juan Carlos, Gladiolo s/n, CP 28933 Móstoles, Madrid, Spain; Instituto de Investigación Sanitaria Fundación Jiménez-Díaz (IIS-FJD), Universidad Autónoma de Madrid (UAM), Hospital Universitario Fundación Jiménez Díaz, Avda. Reyes Católicos, 2, CP 28040 Madrid, Madrid, Spain.
Objective: To evaluate the efficacy of switching to once-weekly subcutaneous semaglutide in patients with type 2 diabetes mellitus (T2DM) who were previously treated with other glucagon-like peptide-1 receptor agonists (GLP-1 RAs) in a real-world setting in Spain.
Methods: The REAL Life study of SEMaglutide in Patients with Type 2 diabetes in Spain (REALSEM-SP) was conducted in four endocrinology departments in Madrid, Spain. Adult patients with T2DM who were prescribed once-weekly (OW) subcutaneous semaglutide and had been previously treated with other GLP-1 RAs were included.
Cancer Rep (Hoboken)
October 2024
Haematology Unit, Careggi University Hospital, Florence, Italy.
Clin Med (Lond)
November 2024
Department of Internal Medicine, School of Medicine, University of Zagreb, Šalata 3, 10000 Zagreb, Croatia; Department of Internal Medicine, Unit for Intensive Care, University Hospital 'Sveti Duh', Sveti Duh 64, Zagreb, Croatia.
Atypical haemolytic-uraemic syndrome (aHUS) is a rare disease associated with uncontrolled activation of the alternative complement pathway, leading to thrombotic microangiopathy (TMA). Early diagnosis and treatment with eculizumab, a monoclonal antibody targeting the complement component C5, are crucial to improve outcomes and prevent renal failure and mortality. Current recommendations include lifelong eculizumab therapy, yet this practice presents challenges including high treatment costs and increased infection risks from prolonged complement inhibition.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!